Skip to content

Evaluation of two type corticosteroids in Treatment of Oral Lichen Planus

Clinical trial of comparative evaluation of effect of Beclomethasone and Adcortyle in treatment of Oral Lichen Planus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101245678N1
Enrollment
19
Registered
2011-07-02
Start date
2009-08-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planus. Diseases of the skin and subcutaneous tissue

Interventions

Intervention 1: Adcortyle was used for treatment of control side. This paste is one of the appropriate drug in treatment oral lichen planus, so used to compare with treatment effect of Bechlomethason
Treatment - Drugs
Adcortyle was used for treatment of control side. This paste is one of the appropriate drug in treatment oral lichen planus, so used to compare with treatment effect of Bechlomethason spray in oral l
Intervention in this article is treatment of oral lichen planus lesions with nasal spray Bechlomethasone dipropionate. Dose of drug was 50ugr/paff and used 4 times a day( 2 puff in each time) after m

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
33 Years to 60 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion: All patients had symptomatic bilateral erosive or ulcerative oral lichen planus with similar intensity, Not used any systemic or topical corticosteroid, Written informed consent was obtained Criteria for exclusion: Patients that were not cooperative , use of another topical or systemic during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Scaling of lesion. Timepoint: 3-6-12 weeks. Method of measurement: REU.;Pain. Timepoint: 3-6-12 weeks. Method of measurement: VAS (Visual Analuge Scaling).;Raughness. Timepoint: 3-6-12 weeks. Method of measurement: VAS.;Maximum diameter of lesion. Timepoint: 3-6-12 weeks. Method of measurement: periodental prob( millimeter).

Secondary

MeasureTime frame
Candidiasis, Mucosal atrophy. Timepoint: 3-6-12 weeks. Method of measurement: Clinical evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Rafieian

Dental Faculty of Hamadam

rafieiann@yahoo.com, abdolsamadi.umsha.ac.ir+98 81 1835 4140

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026